McGrath P C, Neifeld J P, Lawrence W, Kay S, Horsley J S, Parker G A
Department of Surgery, Medical College of Virginia, Richmond 23298-0001.
Ann Surg. 1987 Dec;206(6):706-10. doi: 10.1097/00000658-198712000-00004.
Clinical and pathologic data from 51 patients with primary sarcomas of the gastrointestinal tract treated from 1951 through 1984 were reviewed to determine clinical presentation, histologic features, treatment, and prognostic factors. The most common signs and symptoms were abdominal pain (62%), gastrointestinal bleeding (40%), and/or abdominal mass (38%). The primary site was stomach in 50%, small bowel in 30%, colorectum in 15%, and esophagus in 5%. Virtually all the sarcomas were leiomyosarcomas. Distribution was uniform among the three histologic grades; although 88% of Grade 1 tumors could be completely excised, only 35% of Grade 3 tumors could be completely resected. The 5-year survival rate was 75% for Grade 1 tumors, 16% for Grade 2 tumors, and 28% for Grade 3 tumors (p = 0.0013, Grade 1 vs. 2 and 3). Thirty of the 51 patients (59%) had curative resection with an operative morbidity rate of 24% and an operative mortality rate of 12%; at 5 years the disease-free survival rate was 58% and the overall survival rate was 63% (48% at 10 years). Eleven patients (42%) had recurrent disease develop at a median interval of 2 years after complete tumor excision. Twenty-one patients (41%) had partial excision or biopsy only of their tumors with an operative morbidity rate of 28%, operative mortality rate of 8%, and median survival of only 9 months. Overall, patients whose tumors were confined to the site of origin had a 58% 5-year survival rate compared with 20% for those whose tumors had invaded adjacent organs (p less than 0.05). If the tumor was less than 10 cm in size, the 5-year survival rate was 78%, significantly better than the 38% for tumors greater than 10 cm (p = 0.03). These data suggest that histologic grade, local invasiveness, size, and extent of resection are the most important prognostic factors for patients with primary gastrointestinal sarcomas. Patients who have resection of all gross tumor, especially if it is well differentiated and localized, have a good prognosis.
回顾了1951年至1984年间接受治疗的51例原发性胃肠道肉瘤患者的临床和病理数据,以确定临床表现、组织学特征、治疗方法和预后因素。最常见的体征和症状为腹痛(62%)、胃肠道出血(40%)和/或腹部肿块(38%)。原发部位为胃的占50%,小肠占30%,结肠直肠占15%,食管占5%。几乎所有的肉瘤均为平滑肌肉瘤。三种组织学分级的分布是均匀的;虽然88%的1级肿瘤能够完全切除,但只有35%的3级肿瘤能够完全切除。1级肿瘤的5年生存率为75%,2级肿瘤为16%,3级肿瘤为28%(1级与2级和3级相比,p = 0.0013)。51例患者中有30例(59%)接受了根治性切除,手术发病率为24%,手术死亡率为12%;5年时无病生存率为58%,总生存率为63%(10年时为48%)。11例患者(42%)在肿瘤完全切除后的中位间隔2年出现复发。21例患者(41%)仅对肿瘤进行了部分切除或活检,手术发病率为28%,手术死亡率为8%,中位生存期仅为9个月。总体而言,肿瘤局限于原发部位的患者5年生存率为58%,而肿瘤侵犯相邻器官的患者为20%(p < 0.05)。如果肿瘤大小小于10 cm,5年生存率为78%,显著高于肿瘤大于10 cm的患者的38%(p = 0.03)。这些数据表明,组织学分级、局部侵袭性、大小和切除范围是原发性胃肠道肉瘤患者最重要的预后因素。切除所有大体肿瘤的患者,尤其是如果肿瘤分化良好且局限,预后良好。